Highlights from the 2026 ADeN Conference
The ADeN Conference 2026, held on 16th July, brought together an engaging line-up of speakers to explore “The future of deprescribing: human or artificial intelligence?” The morning featured a keynote presentation from Professor Michael Steinman, followed by a lively six-speaker debate on whether AI is the future of deprescribing, with audience members having their say through a live poll. Dr Shin Liau and Dr Justin Turner opened the conference, with Associate Professor Emily Reeve delivering the closing address and reflecting on the key discussions from the morning.
There was a great turn out with over 60 international and national guests in attendance!

Professor Michael Steinman’s Keynote Address

ADeN Chair, Associate Professor Emily Reeve - giving the closing address

ADeN 2026 Group Photo

Conference Debate: (From left) A/Prof Matthew Doogue, Prof Sarah Hilmer, A/Prof Lisa Kalisch Elliot, Prof Danijela Gnjidic, Prof Michael Steinman and Prof Sepehr Shakib
ADeN Learning Club Recap - July
Our July ADeN Learning Club, held on 2nd July and attended by 67 participants, was one of our highest‑attended sessions to date. It featured a multidisciplinary ‘fireside chat’ exploring deprescribing considerations for an older person living with frailty returning to residential aged care after hospitalisation. We were joined by Josephine To (Palliative Care Pharmacist), Professor Chris Etherton‑Beer (Geriatrician), Professor Sepehr Shakib (Clinical Pharmacologist), and Professor Dee Mangin (GP and Health Researcher) for a rich case discussion on the nuances of deprescribing during a person’s palliative journey.
The panel reflected on key medication decisions, functional decline, and the importance of shared decision‑making, while highlighting practical deprescribing approaches, useful resources, and the value of ongoing communication to support comfort, safety, and quality of life under a palliative approach. The discussion underscored the importance of a person‑centred, holistic, and pragmatic approach that aligns with individual goals of care. It was our first ‘fireside chat’‑style Learning Club, and we look forward to more thought‑provoking, multidisciplinary conversations in the future - watch this space for our next Learning Club coming up soon!
To access the webinar recording, please visit the link: https://www.youtube.com/watch?v=MPMMTXYPO8Q

Research Opportunities
Guiding conversations about opioid tapering
The aim of this research is to elicit perspectives of Australian clinicians on the preferred content, language and format of an opioid tapering conversation guide. Participants’ input will help us to refine this resource to enhance feasibility, acceptability and usefulness.
Participation involves a one-on-one interview via videoconference (Zoom). The interview will take approximately 30-60 minutes and will be audio-recorded.
Who can take part:
Participants who are registered healthcare professionals in Australia, with experience in the prescribing (or deprescribing), dispensing or administration of opioids.
For more information, please review the Participant Information Statement here.

Developing evidence-based resources for older adults to support person-centred opioid deprescribing
Who can take part:
Older adults aged 65 years or older (or 50 years or older for Aboriginal and Torres Strait Islander people) who have chronic non-cancer pain and are currently taking, or have taken within the past 12 months, opioid medicines for pain management.
Family members or carers of older adults who meet the above criteria.
Participants will be invited to take part in a one-on-one interview or focus group via videoconference or face-to-face, lasting approximately 30-60 minutes. Sessions will be audio-recorded with participants' consent. Older adults and their family member/carer may choose to participate together, participate independently, or have a non-participating support person present during the interview if desired.
As a token of appreciation, participants will receive a $50 electronic gift card for a retailer of their choice.
Individuals interested in participating or learning more about the study can read the full explanatory statement and complete the expression of interest form here: https://tinyurl.com/4mvthjad
If you have any questions, please do not hesitate to contact [email protected]
(approved by Monash University Human Research Ethics Committee - Project 41201).

Did someone send you this email? Subscribe here if you would like to keep in touch
